A Study to Evaluate the Food Effect on RNK08954 in Healthy Participants, and the Mass Balance Study of [14C]RNK08954 in Healthy Adult Male Subjects

Phase 1 Not yet recruiting 24 enrolled Ranok Therapeutics (Hangzhou) Co., Ltd.

RandomizedCrossoverOpen-labelTreatment

Summary

An Study of Orally Administered RNK08954 in Healthy Adult Subjects to Determine the Effect of Food on the Pharmacokinetics of RNK08954，Mass Balance Study of \[14C\] RNK08954 in Chinese Healthy Adult Male Subjects

Timeline

Start: 2025-12-31
Primary completion: 2026-12-01
Completion: 2026-12-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	RNK08954	Unknown	1200 mg	Oral

Indications

No indication recorded.